Hemidesmosomes (HDs) are multiprotein structures that anchor epithelia to the basement membrane. During squamous cell carcinoma (SCC) invasion, there is a reduction in the number of HDs, which may facilitate dissemination. Mechanisms of HD disassembly are incompletely understood. Previous work has shown that epidermal growth factor (EGF)-induced phosphorylation of the b4 integrin on three of its serines, S 1356 S 1360 S 1364 , can induce HD disassembly in normal cells. Here, we examine the role of b4 integrin serine phosphorylation in SCC. We have found that around 60% of invasive cutaneous SCC show increased b4 phosphorylation on S 1356 when compared with carcinoma in situ or normal tissue. To assess the mechanisms by which SCC increases b4 phosphorylation, we performed in vitro analyses. Compared with keratinocytes, SCC cells showed increased levels of S 1356 phosphorylation in the absence of EGF, correlating with reduced HD-like structures. In addition, phospho-S 1356 signal was largely segregated from other HD components. Epidermal growth factor receptor and PKC inhibitors inhibited basal levels of S 1356 phosphorylation in SCC, suggesting that cells use intrinsic mechanisms to activate the EGF signaling pathway to induce b4 phosphorylation. Moreover, these inhibitors stabilized HD-like structures in SCC cells and reduced their migratory ability. Mutation of S 1356 S 1360 S 1364 in SCC cells to non-phosphorylatable alanines stabilized HD-like structures and substantially reduced migration, while mutation into phosphorylation mimicking aspartate reduced HD-like structures but had no effect on migration, suggesting that serine phosphorylation function is releasing anchorage rather than promoting migration. Altogether these results suggest that b4 serine phosphorylation may have an important role during SCC invasion by destabilizing HDs and facilitating migration.
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Hemidesmosomes (HDs) are multiprotein structures that anchor epithelia to the basement membrane. During squamous cell carcinoma (SCC) invasion, there is a reduction in the number of HDs, which may facilitate dissemination. Mechanisms of HD disassembly are incompletely understood. Previous work has shown that epidermal growth factor (EGF)-induced phosphorylation of the b4 integrin on three of its serines, S 1356 S 1360 S 1364 , can induce HD disassembly in normal cells. Here, we examine the role of b4 integrin serine phosphorylation in SCC. We have found that around 60% of invasive cutaneous SCC show increased b4 phosphorylation on S 1356 when compared with carcinoma in situ or normal tissue. To assess the mechanisms by which SCC increases b4 phosphorylation, we performed in vitro analyses. Compared with keratinocytes, SCC cells showed increased levels of S 1356 phosphorylation in the absence of EGF, correlating with reduced HD-like structures. In addition, phospho-S 1356 signal was largely segregated from other HD components. Epidermal growth factor receptor and PKC inhibitors inhibited basal levels of S 1356 phosphorylation in SCC, suggesting that cells use intrinsic mechanisms to activate the EGF signaling pathway to induce b4 phosphorylation. Moreover, these inhibitors stabilized HD-like structures in SCC cells and reduced their migratory ability. Mutation of S 1356 S 1360 S 1364 in SCC cells to non-phosphorylatable alanines stabilized HD-like structures and substantially reduced migration, while mutation into phosphorylation mimicking aspartate reduced HD-like structures but had no effect on migration, suggesting that serine phosphorylation function is releasing anchorage rather than promoting migration. Altogether these results suggest that b4 serine phosphorylation may have an important role during SCC invasion by destabilizing HDs and facilitating migration. KEYWORDS: cell migration; hemidesmosome; integrins; invasion; phosphorylation Squamous cell carcinomas (SCCs) are highly invasive tumors capable of metastasis. [1] [2] [3] Stratified squamous epithelia, where most of the SCCs originate from, are strongly attached to the basal lamina through hemidesmosomes (HDs), multiprotein structures that provide stability. 4, 5 During wound healing or SCC invasion, there is an increase in HD disassembly. 6, 7 In some SCC types, HD disassembly has been shown to correlate with metastatic potential. 7 For this reason, there is a considerable interest to understand the mechanisms of HD disassembly.
The mechanisms of HD disassembly are not completely understood. Studies suggest that phosphorylation of the a6b4 integrin, has an important role in HD disassembly. [8] [9] [10] [11] [12] The a6b4 integrin is the main organizer of HDs.
13 a6b4 connects to laminin on the basal lamina and facilitates the assembly of other HD components, including plectin and BPAG1 (bullous pemphigoid antigen 1), which link a6b4 to cytokeratins. 4, 5, 13 The chain of events that leads to HD disassembly in SCC is not well understood. Growth factors might trigger the initial events. Supporting this idea, epidermal growth factor (EGF) and macrophage-stimulating protein have been shown to induce HD disassembly in vitro. [14] [15] [16] These factors activate signaling pathways that result in b4 phosphorylation. EGF induces phosphorylation of b4 on serine and tyrosine residues, several of which have been identified and shown to be involved in HD disassembly. [8] [9] [10] [11] 14 Around 95% of b4 phosphorylation induced by EGF occurs on serine, 8, 15 mostly on four sites, S 1356 , S 1360 , S 1364 , and S 1424 . 8, 9, 11 In normal cells, substitution of these serines with alanine impedes phosphorylation and in a cooperative manner can inhibit EGF-induced HD disassembly. 8, 9, 11 The mechanism by which b4 serine phosphorylation induces disruption of HDs is unclear, although evidence suggests that S 1356 S 1360 S 1364 phosphorylation controls a6b4/plectin interaction.
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One possible scenario to explain reduced HDs in SCC is that b4 phosphorylation may be altered, changing the balance toward disassembly. There is little information about b4 phosphorylation in SCC or its impact on HDs in cell migration. In this study, we analyzed b4 phosphorylation in primary SCC as well as in SCC cells in vitro. SCC frequently shows alterations in EGF receptor (EGFR) signaling, 17 ,18 so we analyzed phospho-S 1356 , a b4 residue whose phosphorylation is EGF dependent. We found that S 1356 phosphorylation in primary SCC correlates with invasiveness. In vitro analysis showed that SCC cells have intrinsic mechanisms to increase the basal level of b4 phosphorylation in the absence of EGF, reducing HD-like structures stability. Interestingly, SCC cells still use EGFR and PKC in the absence of exogenous EGF. Gefitinib, an EGFR kinase inhibitor, increased HD-like structures stability by reducing b4 phosphorylation, affecting cell migration as well. Mutation of b4 S 1356 S 1360 S 1364 into alanines stabilized HD-like structures and hindered SCC migration. Our results suggest that b4 phosphorylation has an important role in SCC progression by altering HD stability and the ability of cells to migrate. Targeting HD stability may be a method to reduce the ability of SCC to disseminate.
MATERIALS AND METHODS
Cells and Reagents SCC cell lines: A431 cells were obtained from ATCC; Colo-16 cells were obtained from Dr N Hail (University of Colorado, Denver, CO, USA); SCC-25 cells were provided by Dr AM Mercurio (UMass Med, Worcester, MA, USA). HaCaT keratinocytes were obtained from Dr S La Flamme (Albany Medical College, Albany, NY, USA). All cells were maintained in DMEM with 10% fetal calf serum, except SCC-25 that was maintained in a 1:1 mixture of DMEM and Ham's F12 medium supplemented with 400 ng/ml hydrocortisone and 10% fetal bovine serum. Antibodies: 3E1 (b4, Chemicon); GoH3 (a6, Chemicon); rabbit anti-b4; 15 anti-BPAG1; 19 antiplectin (Santa Cruz Biotechnology); affinity-purified phospho-specific rabbit polyclonal Ab (anti-phospho-S 1356 Ab) raised against b4 peptide DDVLR(pS)PSGSQ (custom-made, QBC, Hopkinton, MA, USA).
Plasmids b4shRNA-A431cells pLKO.1b4-shRNA TRCN0000057768 (Open Biosystems) against an untranslated region of b4 was used to inhibit b4 endogenous expression in A431. pLKO.1GFP-shRNA was used as control. Cells were puromycin selected.
b4-PCLXSN and triple mutants b4 Integrin cDNA fused to a C-terminus myc tag was inserted in PCLXSN retroviral vector (Imgenex). A triple mutation ser-ala or ser-asp on S 1356 S 1360 S 1364 was introduced into b4-myc using standard techniques. 9 Retroviral particles were used to infect b4shRNA-A431cells. As control, we used the empty vector. Cells were selected using G418 and b4-negative cells were eliminated by FACS sorting.
Indirect Immunofluorescence Cells were stained as described previously. 15, 20 Briefly, cells grown on coverslips were extracted or not, with detergent buffer containing 0.5% Triton-X-100, 100 mM KCl, 200 mM sucrose, 10 mM EGTA, 2 mM MgCl2, and 10 mM PIPES at pH 6.8 for 1 min, then fixed using paraformaldehyde or methanol. Cells were rinsed, blocked and stained with indicated Abs and Cy2/Cy3-conjugated secondaries. Slides were analyzed using fluorescence microscopy. Analysis of HD-like structures: collected images were background-subtracted, thresholded and fluorescence integrated density per cell was calculated using ImageJ software (NIH).
In Vitro Wound Healing Assay Cells grown to confluency were scratched with a yellow tip, and new medium containing inhibitors or not, was added. Image records were collected at time 0. Wounded plates were incubated for 8-24 h. Images were collected and percentage of wound closure was determined by digital analysis.
Human Tissue Samples
Tissue sections were obtained from the Cancer Center Tissue and Tumor Bank of UMASSMed with IRB approval. Formalin-fixed paraffin-embedded (FFPE) sections were stained with indicated antibodies using standard immunoperoxidase technique. Frozen sections were fixed in methanol, rinsed, blocked, and stained with indicated antibodies followed by cy2/cy3-conjugated secondaries. Slides were analyzed by fluorescence microscopy. Staining intensities were scored from 0 (absent) to 4 (very strong) by two observers (SL and IR). Colocalization analysis in frozen sections was performed using ImageJ (NIH) and Colocalization Threshold plugin 21 (http://www.uhnresearch.ca/facilities/wcif/software/Plugins/ colocalisation_threshold.html). Statistical analysis was performed using t-test.
RESULTS
Phosphorylation of the b4 Integrin in Primary Human SCC Correlates With Invasion EGF signaling is frequently altered in SCC. 17, 18 We have previously identified S 1356 as one of the main phosphorylation sites on the b4 integrin that is phosphorylated upon EGF stimulation in a PKC-dependent manner using peptide mapping analysis, results that have been confirmed by other groups. 8, 11 We and others have also shown that S 1356 phosphorylation contributes importantly in HD disassembly. 8, 11 b4 Integrin in squamous cell carcinoma T Kashyap et al Therefore, we generated a phospho-specific Ab against phospho-S 1356 . To assess Ab specificity, we mutated b4 S 1356 -A 1356 to prevent Ab recognition of phospho-S 1356 . As shown in Figure 1a , mutation of the residue eliminated the phospho-S 1356 Ab signal, confirming specificity. To confirm that the Ab acts in accordance to previous studies, we evaluated the kinetics of S 1356 phosphorylation in HaCaT keratinocytes during EGF stimulation using phospho-S 1356 Ab and western analysis. As shown in Figure 1b , there is little phosphorylation in non-stimulated cells, rapidly increasing to high levels after 5 min and maintaining levels for 2 h. Previous work suggests that phosphorylation of some of the serines in S 1356 S 1360 S 1364 serine cluster are PKC dependent. 8, 11 Therefore, we analyzed the effects of PKC stimulators and inhibitors on S 1356 phosphorylation. As shown in Figure 1c , EGFdependent phosphorylation can be inhibited with conventional PKC inhibitor Go6976. Furthermore, PKC stimulator PMA induces S 1356 phosphorylation, suggesting PKC dependence. Altogether these results indicate that the Ab is specific and performs as expected in accordance to previous work.
To assess the prevalence of b4 phosphorylation in human SCC, we analyzed S 1356 phosphorylation in normal skin and primary SCC. Archival FFPE or frozen sections were analyzed using immunohistochemistry (IHC) or immunofluorescence (IF) analysis, respectively. FFPE sections from 20 cutaneous SCC were stained for phospho-S 1356 . Tissues were divided into five categories: normal skin (n ¼ 4); carcinoma in situ (n ¼ 7); well (n ¼ 4), moderately (n ¼ 5), or poorly differentiated (n ¼ 4) invasive carcinoma. Staining intensities were scored 0 ¼ absent to 4 ¼ very strong. In normal skin, b4 was expressed in basal cells ( Figure 2a ) as previously described. 22 Phospho-S 1356 stain was mostly negative (Figure 2b ). In carcinoma in situ, b4 was highly expressed (Figure 2c ), sometimes observed in suprabasal levels, and there was little b4 phosphorylation ( Figure 2d ). In invasive carcinomas, b4 expression remained high, sometimes extending beyond the basal layer (Figures 2e  and g ). In contrast to normal skin and carcinoma in situ, invasive SCC showed increased phospho-S 1356 (Figures 2f and h). The signal was specific because it was eliminated by incubating the primary antibody in the presence of competing phospho-S 1356 peptide, or by treating the tissue with alkaline phosphatase before adding the primary antibody (results not shown). Around 60% of the invasive tumors showed high levels of phospho-S 1356 with IHC scores higher than normal skin (Figure 2i ). However, we found no difference between invasive carcinomas according to their degree of differentiation. b4 phosphorylation could be found along the tumor/stroma interface (Figure 2h ), or extending deeply into the tumor (Figure 2f ) usually codistributing with b4. The increased phosphorylation of the b4 integrin in invasive SCC suggests that phosphorylation may have a role during this tumor progression phase.
Distribution Pattern of b4 Phosphorylation in Relation to Total b4, Basement Membrane and Other HD Components in Human SCC
To assess more closely the relationship between the b4 phosphorylation signals and total b4, other HD components or the basement membrane in human SCC, we analyzed nine cutaneous SCC (all invasive, three well and six moderately differentiated) and two normal skin frozen sections using double IF. Consistent with IHC results, normal skin showed high levels of b4 expression and little b4 phosphorylation (Figures 3a-c) . About 60% of the invasive SCC sections showed moderate-to-high levels of b4 phosphorylation (Figures 2i and 3e , h, and k). b4 phosphorylation varied within regions, frequently showing gaps in relation to the band-like signal of b4 (arrows Figures 3e, f, h, and i), suggesting that phosphorylation is regionally modulated. Phosphorylation was stronger at the tumor/stroma interface sometimes extending more deeply (Figures 3e and h ), similar to FFPE sections.
To assess whether the discontinuous pattern of b4 phosphorylation corresponds to basement membrane disruptions along the tumor/stroma interface, we analyzed colocalization of phospho-S 1356 and Laminin-332. As shown in Figures 3g-i, Laminin-332 was continuous and did not correlate with the patchy pattern of b4 phosphorylation, suggesting that b4 phosphorylation is unrelated to the basement membrane. To assess if b4 phosphorylation affects the distribution of other HD components, we evaluated colocalization of BPAG1 and phospho-S 1356 . The patchy pattern of both BPAG1 and b4 phosphorylation frequently excluded each other (Figures 3j-l) , suggesting that b4 phosphorylation may affect the distribution of this HD component. The higher levels of phosphorylation observed in invasive primary SCC and previous observations that HDs are reduced in SCC 7 prompted us to assess in vitro for possible mechanisms explaining these observations. Reduced HDs in SCC may be related to alterations in b4 phosphorylation. We, therefore, analyzed the levels and distribution of S 1356 phosphorylation in three SCC cell lines: A431, 23 SCC-25 24 and Colo-16 25 in relation to HaCaT keratinocytes, which are immortalized keratinocytes capable of differentiation in organotypic cultures and formation of HD-like structures in vitro. 26 Western analysis showed that, in comparison to HaCaT keratinocytes, all SCC cells had elevated basal levels of phospho-S 1356 in the absence of EGF (Figures 4a and b) , suggesting intrinsic mechanisms to increase phosphorylation. We then compared the phospho-S 1356 distribution between HaCaT keratinocytes and SCC cells using IF (Figures 4c and e) . The cells were dual immunostained with b4 and phospho-S 1356 Abs. HaCaT keratinocytes showed characteristic HDlike structures stained with the b4 Ab that largely survived extraction with detergent buffer before fixation (Figure 4c ; non-Ex: non-extracted; Ex: extracted). The resistance to detergent buffer is mostly conferred by the connection of the b4 integrin with the cytokeratins through plectin and BPAG1. 27, 28 As expected, most of the b4 that remains after detergent extraction in HD-like structures colocalizes with plectin ( Figure 4d) . Using quantitative IF, we determined that about 60% of HaCaT b4 is resistant to detergent (Figure 4e) . The phospho-S 1356 signal was low in HaCaT keratinocytes (Figure 4c ). In contrast, SCC cells showed a higher phospho-S 1356 signal in all three SCC cell lines (Figure 4c ), which colocalized with b4 in HD-like structures and retraction fibers (Figures 4e and 5a-c) . However, b4 signal was less resistant than HaCaT keratinocytes to detergent extraction (B20%; Figure 4e ). Most of the phosphorylation signal in the SCC cells was not resistant to detergent (Figure 4e ). These findings are consistent with the notion that b4 phosphorylation weakens HD stability.
Previous studies suggest that phosphorylated S 1356 S 1360 S 1364 promotes disruption of b4-plectin interactions. 11 We therefore assessed phospho-S 1356 /plectin and plectin/total b4 colocalization in SCC cells. A similar pattern was found for all SCC types (exemplified by SCC-25 in Figure 5) , showing that while plectin usually colocalized with total b4 in stabilized HD-like structures as previously described 29 (Figures 5d-f) , phospho-S 1356 only partially overlapped with plectin and interestingly, within colocalized areas, an inverse gradient between the two signals was frequently observed (Figures 5g-i) , suggesting that plectin may be gradually removed as more b4 becomes phosphorylated. We also assessed colocalization of phospho-S 1356 or total b4 with BPAG1, another linker of b4 with cytokeratins. While BPAG1 always colocalized with parts of the total b4 (Figures 5j-l) , a sharper segregation was seen Figure 3 Distribution pattern of b4 phosphorylation in human SCC frozen sections: discontinuous patches that can exclude other HD components. Frozen sections from skin (a-c) or invasive SCC (d-l) were dual-immunostained using Abs against (indicated within image): phospho-S 1356 (red); and b4, Laminin-332 or BPAG1 (green). Colocalization in the third column was determined by threshold correlation analysis, 21 which shows correlating areas above threshold in white (colocalizing) or below threshold in red or green (non-colocalizing). e, epidermis; d, dermis; bm, basement membrane; t, tumor; s, stroma. Bar ¼ 100 mm. Notice that b4 phosphorylation may range from mildly discontinuous (e) to highly discontinuous (h). Laminin-332 is mostly continuous and does not follow phospho-S 1356 gaps (g-i). While both BPAG1 and phospho-S 1356 phosphorylation are discontinuous they show segregation more frequently (j-l). (Figures 5m-o) , suggesting that other HD components are affected by phospho-S 1356 as well. Altogether these results suggest that SCC cells have intrinsic mechanisms to induce b4 phosphorylation that might disrupt interactions among HD components, decreasing HD-like structure stability.
Intrinsic Activation of EGFR Signaling Pathway in SCC Cells Raises Phospho-S 1356 Basal Levels Affecting HD-Like Structure Stability and Cell Migration
To address the mechanisms that could generate an increase in the basal levels of b4 phosphorylation in SCC, we determined whether this increase still depends on the EGF/PKC pathway. We evaluated phospho-S 1356 in the presence or absence of EGFR inhibitor Gefitinib or PKC inhibitor Go6976. As shown in Figure 6a , both Gefitinib and Go6976 inhibit phospho-S 1356 basal levels in SCC cells, suggesting that activation of EGFR and PKC is still necessary in the absence of an external source of EGF and that SCC cells have intrinsic mechanisms to activate these kinases.
Since Gefitinib is used in some types of SCC chemotherapy, 30 we addressed whether this drug could exert some of its anti-tumor effects through HD stabilization and modifying cell migration. As shown in Figure 6b , b4 in HD-like structures is substantially increased using Gefitinib or Go6976. We then assessed their effect on SCC migration using in vitro wound healing assays. Both inhibitors efficiently reduced migration in all cells (Figure 6c ). Go6976 effect was more pronounced, suggesting that alternative signaling pathways may converge with EGF signaling to activate PKC. These results suggest that anti-tumor activity of Gefitinib might include inhibition of SCC cell migration through HD stabilization and inhibition of b4 phosphorylation.
Prevention of b4 Phosphorylation on S 1356 S 1360 S 1364
Restores HD-Like Structures in SCC Cells and Slows Migration Cell migration is an important component of carcinoma invasion and metastasis. 31 Considering that SCC invasion correlates with b4 phosphorylation and reduction of HD-like structures, we hypothesized that by preventing S 1356 S 1360 S 1364 phosphorylation in SCC, we would replenish HD-like structures and hinder migration. Previous work in normal cells has shown that triple mutation is needed to increase HD stability. 8, 11 We therefore expressed in A431 a nonphosphorylatable triple mutant b4-A 1356 A 1360 A 1364 -myc or a phosphorylation mimicking mutant b4-D 1356 D 1360 D 1364 -myc, using wild-type (wt) b4-myc as control. We first silenced b4 endogenous expression in A431 using shRNA technology (targeting b4 non-translated region). We then expressed wt and mutant b4 at equivalent levels (Figure 7a ). Using IF analysis and detergent extraction to assess HD-associated b4, we found that b4-myc and b4-A 1356 A 1360 A 1364 -myc incorporated well into HD-like structures (Figure 7b , non-extracted vs extracted). A quantitative analysis showed that b4-A 1356 A 1360 A 1364 -myc produced twice the amount of HD-like structures as b4-myc (Figure 7c ). In contrast, incorporation of b4-D 1356 D 1360 D 1364 -myc into HD-like structures was reduced (Figures 7b and c) . We addressed whether HD-like structure stabilization induced by b4-A 1356 A 1360 A 1364 -myc can counter EGF-induced HD disruption. As shown in Figure 7c b4 Integrin in squamous cell carcinoma T Kashyap et al disruption while b4-myc was largely mobilized. These data suggest that low number of HD-like structures in SCC can be reverted by preventing b4 phosphorylation.
We then assessed the ability of b4 phosphorylation mutants to influence cell migration using wound healing assay. As shown in Figure 7d , b4-A 1356 A 1360 A 1364 -myc substantially reduced A431 migration. However, the phosphorylation mimicking mutant did not affect migration. These results suggest that regulation of b4 phosphorylation can modulate cell movement through HD destabilization, although once b4 leaves HDs, serine phosphorylation provides no further advantage.
DISCUSSION
HDs disassemble during wound healing and carcinoma invasion. In some types of SCC, the reduction of HDs is also associated with high metastatic potential. 7 In this paper, we have explored the possibility that reduction of HDs in SCC is due to b4 integrin serine phosphorylation. Consistent with this idea, we have found a correlation between an increase in b4 integrin phosphorylation and carcinoma invasion in a group of 29 primary cutaneous SCC. This is the first report showing that b4 phosphorylation occurs in human tissue. The analysis of the b4 phosphorylation in FFPE and frozen tissues showed a clear increase in phospho-S 1356 signal in B60% of the invasive SCC. However, we did not detect significant differences between the various degrees of differentiation among the invasive tumors. The phosphorylation signal was distributed unevenly, showing frequent gaps in the interface between the SCC and stroma, suggesting that the phosphorylation may be dependent on the context of the tumor location. Considering that EGFR activation is frequently seen in SCC and that b4 can be phosphorylated through EGF signaling, one possible scenario to explain regional variations of b4 phosphorylation would be a concomitant activation of EGFR within the same areas. We made efforts to detect phospho-EGFR and, although we found that SCC expressed EGFR, we were not able to detect phospho-EGFR (results not shown), a problem that has also been encountered by others studying cutaneous SCC. 18 Interestingly, in other types of SCC, the existence of regional variations in phospho-EGFR has been reported, 32 reminiscent of b4 phosphorylation pattern. Another possibility is that regional phosphorylation of the b4 integrin might reflect gaps in the basement membrane, a phenomenon that frequently occurs in invasive carcinoma. However, we found no relationship between the b4 phosphorylation pattern and the basement membrane, which mostly showed a continuous distribution of Laminin-332, suggesting that b4 phosphorylation is not determined by the basement membrane organization.
To gain more insight into what causes an increase in b4 phosphorylation in SCC, we used an in vitro model of SCC. Our in vitro results suggest that SCC cells acquire intrinsic mechanisms to increase b4 phosphorylation in the absence of any added growth factor. This increase of b4 basal phosphorylation in SCC cells is accompanied by a reduction of HD-like structures and segregation of the phosphorylation signal in relation to the HD components plectin and BPAG1, results that are consistent with the notion that b4 phosphorylation promotes disassembly of HDs through the disruption of interactions with other HD components.
8,11
Interestingly, we also observed segregation of BPAG1 and b4 phosphorylation signal in SCC tissues, although the complete disappearance of BPAG1 within groups of cells in SCC suggests a different mechanism of segregation whereby b4 Integrin in squamous cell carcinoma T Kashyap et al continuous b4 phosphorylation might eventually affect BPAG1 turnover or expression. Clearly, more studies are necessary to understand the long-term effects of b4 phosphorylation on other HD components. One shared mechanism that the three SCC cell lines use to increase the basal phosphorylation of the b4 integrin is the maintenance of an active EGFR in the absence of added growth factor, indicated by the inhibition of b4 phosphorylation with Gefitinib, an EGFR kinase inhibitor. An active EGFR in such conditions would suggest the possibility of autocrine secretion of EGFR ligands or sensitizing mutation/amplification of EGFR. Constitutive activation of EGFR through expression of autocrine EGFR ligands, gain-of-function mutations, or protein overexpression is found in nearly 90% of all oral cavity and head and neck SCCs. 2, 30, 33 In the specific case of A431, overexpression of EGFR and autocrine stimulation with TGF is well documented and may explain the increase in b4 phosphorylation. 34, 35 Importantly, the inhibition of b4 phosphorylation by Gefitinib correlated with stabilized HD-like structures and reduced cell migration in all SCC cells, suggesting that EGF effect on migration may be in part due to the regulation of b4 phosphorylation promoting HD disassembly and allowing cells to move. Downstream EGFR, PKC still seems to mediate increased S 1356 phosphorylation in SCC as shown by the inhibitory action of Go6976, a conventional PKC inhibitor. 36 Therefore, SCC cells may only differ from keratinocytes in some type of disregulation of the EGF signaling pathway rather than the activation of an alternative route.
Our data suggest that b4 phosphorylation might be involved in regulating the invasive ability of SCC through modulation of HD stability and cell migration. First, our results show that by inhibiting b4 phosphorylation with Gefitinib in SCC cells, there was clear stabilization of HD-like structures, which correlated with cell migration inhibition. The effect on HD-like structure stability and cell migration was somewhat stronger using Go6976, suggesting that alternative signaling pathways may converge in the activation of PKC. Second, by preventing the phosphorylation of b4 through mutation of the serine cluster S 1356 S 1360 S 1364 to alanines, we were able to increase HD-like structure stability and inhibit migration even in the presence of EGF. However, a phosphorylation mimicking mutation of the serine cluster to aspartate failed to increase migration. This suggests that the role of b4 integrin serine phosphorylation in SCC migration is to release the cell from migration-hindering attachment rather than actively promote migration. It is worth mentioning that b4 per se was still necessary for cell migration, since silencing b4 reduced migration, which is in agreement with previous studies, suggesting that b4 itself promotes migration and invasion through a variety of signaling pathways. 37, 38 In this regard, a role of b4 tyrosine phosphorylation in the migration-promoting function of b4 has been previously shown. [39] [40] [41] [42] An interesting implication of our findings is that some of the anti-tumorigenic effects of EGFR inhibitors, such as Gefitinib, might be exerted through the stabilization of HDs by inhibiting b4 serine phosphorylation and consequently affecting the migration capability of the tumor, which ultimately impacts metastatic potential. Future studies that evaluate the restoration of HDs and reduction of b4 phosphorylation during Gefitinib treatments could be potentially useful in assessing treatment efficiency and providing additional prognosis value.
